European drugmaker Novartis (NVS), best known for blockbuster drugs like Entresto, Cosentyx, and Kesimpta, just announced a major U.S. investment. The $200 billion pharma company intends to invest $23 ...

US stock futures fell as President Trump's rapid trade policy shifts kept investors on edge ahead of the next batch of corporate earnings.